• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组 CRISPR 筛选鉴定调控 SARS-CoV-2 进入的宿主因子。

A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.

机构信息

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Biosafety Level 3 Laboratory, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.

Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China.

出版信息

Nat Commun. 2021 Feb 11;12(1):961. doi: 10.1038/s41467-021-21213-4.

DOI:10.1038/s41467-021-21213-4
PMID:33574281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7878750/
Abstract

The global spread of SARS-CoV-2 is posing major public health challenges. One feature of SARS-CoV-2 spike protein is the insertion of multi-basic residues at the S1/S2 subunit cleavage site. Here, we find that the virus with intact spike (Sfull) preferentially enters cells via fusion at the plasma membrane, whereas a clone (Sdel) with deletion disrupting the multi-basic S1/S2 site utilizes an endosomal entry pathway. Using Sdel as model, we perform a genome-wide CRISPR screen and identify several endosomal entry-specific regulators. Experimental validation of hits from the CRISPR screen shows that host factors regulating the surface expression of angiotensin-converting enzyme 2 (ACE2) affect entry of Sfull virus. Animal-to-animal transmission with the Sdel virus is reduced compared to Sfull in the hamster model. These findings highlight the critical role of the S1/S2 boundary of SARS-CoV-2 spike protein in modulating virus entry and transmission and provide insights into entry of coronaviruses.

摘要

SARS-CoV-2 的全球传播带来了重大的公共卫生挑战。SARS-CoV-2 刺突蛋白的一个特征是在 S1/S2 亚基切割位点插入多个碱性残基。在这里,我们发现完整刺突(Sfull)的病毒优先通过细胞膜融合进入细胞,而缺失破坏多碱性 S1/S2 位点的克隆(Sdel)则利用内体进入途径。我们使用 Sdel 作为模型进行全基因组 CRISPR 筛选,并鉴定出几个内体进入特异性调节剂。CRISPR 筛选的命中的实验验证表明,调节血管紧张素转换酶 2(ACE2)表面表达的宿主因子会影响 Sfull 病毒的进入。与 Sfull 相比,Sdel 病毒在仓鼠模型中的动物间传播减少。这些发现强调了 SARS-CoV-2 刺突蛋白 S1/S2 边界在调节病毒进入和传播中的关键作用,并为冠状病毒的进入提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/2721a1cb5d94/41467_2021_21213_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/b5745ceff977/41467_2021_21213_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/307188ad91e6/41467_2021_21213_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/71b4bbda2b34/41467_2021_21213_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/f536d3f5054e/41467_2021_21213_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/2721a1cb5d94/41467_2021_21213_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/b5745ceff977/41467_2021_21213_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/307188ad91e6/41467_2021_21213_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/71b4bbda2b34/41467_2021_21213_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/f536d3f5054e/41467_2021_21213_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ee/7878750/2721a1cb5d94/41467_2021_21213_Fig5_HTML.jpg

相似文献

1
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.全基因组 CRISPR 筛选鉴定调控 SARS-CoV-2 进入的宿主因子。
Nat Commun. 2021 Feb 11;12(1):961. doi: 10.1038/s41467-021-21213-4.
2
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.弗林蛋白酶和 TMPRSS2 在 SARS-CoV-2 感染中的独特作用。
J Virol. 2022 Apr 27;96(8):e0012822. doi: 10.1128/jvi.00128-22. Epub 2022 Mar 28.
3
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.SARS-CoV-2 刺突蛋白中的弗林裂解位点是在雪貂中传播所必需的。
Nat Microbiol. 2021 Jul;6(7):899-909. doi: 10.1038/s41564-021-00908-w. Epub 2021 Apr 27.
4
The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.TRAF3-DYRK1A-RAD54L2 复合物维持 ACE2 表达以促进 SARS-CoV-2 感染。
J Virol. 2024 May 14;98(5):e0034724. doi: 10.1128/jvi.00347-24. Epub 2024 Apr 23.
5
Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.人类血管紧张素转换酶2(ACE2)和跨膜丝氨酸蛋白酶2(TMPRSS2)在决定新型冠状病毒肺炎(COVID-19)宿主-病原体相互作用中的作用。
J Genet. 2021;100(1). doi: 10.1007/s12041-021-01262-w.
6
Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.全基因组 CRISPR 筛选揭示了宿主感染 SARS-CoV-2 的关键因素。
Cell. 2021 Jan 7;184(1):76-91.e13. doi: 10.1016/j.cell.2020.10.028. Epub 2020 Oct 20.
7
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.SARS-CoV-2 和 SARS-CoV 的刺突介导的细胞融合在受体表达和蛋白水解激活的要求上存在差异。
J Virol. 2021 Apr 12;95(9). doi: 10.1128/JVI.00002-21.
8
SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis.SARS-CoV-2 通过网格蛋白介导的内吞作用感染细胞。
J Biol Chem. 2021 Jan-Jun;296:100306. doi: 10.1016/j.jbc.2021.100306. Epub 2021 Jan 19.
9
SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.SARS-CoV-2 刺突蛋白的弗林蛋白酶裂解位点和 S2'碱性残基以宿主细胞依赖的方式调节进入过程。
J Virol. 2022 Jul 13;96(13):e0047422. doi: 10.1128/jvi.00474-22. Epub 2022 Jun 9.
10
Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.SARS-CoV-2 刺突蛋白在 S1/S2 边界处的蛋白水解激活:除弗林蛋白酶以外的蛋白酶的潜在作用。
ACS Infect Dis. 2021 Feb 12;7(2):264-272. doi: 10.1021/acsinfecdis.0c00701. Epub 2021 Jan 12.

引用本文的文献

1
Glycosylphosphatidylinositol biosynthesis functions as a conserved host defense pathway against coronaviruses via regulation of LY6E.糖基磷脂酰肌醇生物合成通过对LY6E的调控,作为一种针对冠状病毒的保守宿主防御途径发挥作用。
PLoS Pathog. 2025 Sep 3;21(9):e1013441. doi: 10.1371/journal.ppat.1013441. eCollection 2025 Sep.
2
Advancements in CRISPR-Cas Systems for Genome Editing towards Eradication of Human Microbial Pathogens.用于基因组编辑以根除人类微生物病原体的CRISPR-Cas系统的进展
Mol Biotechnol. 2025 Aug 20. doi: 10.1007/s12033-025-01482-w.
3
DAZAP2 functions as a pan-coronavirus restriction factor by inhibiting viral entry and genomic replication.

本文引用的文献

1
The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection.单细胞 RNA 测序表达谱分析受体 ACE2 和细胞蛋白酶 TMPRSS2,揭示了人类易感染 SARS-CoV-2 的器官。
Int J Environ Res Public Health. 2021 Jan 2;18(1):284. doi: 10.3390/ijerph18010284.
2
Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin.附录:与一种可能源自蝙蝠的新型冠状病毒相关的肺炎疫情。
Nature. 2020 Dec;588(7836):E6. doi: 10.1038/s41586-020-2951-z.
3
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.
DAZAP2通过抑制病毒进入和基因组复制,作为一种泛冠状病毒限制因子发挥作用。
mBio. 2025 Aug 20:e0038525. doi: 10.1128/mbio.00385-25.
4
Characterization of private mutations in the spike protein of SARS-CoV-2 correlates with viral prevalence.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白中私有突变的特征与病毒流行率相关。
BMC Infect Dis. 2025 Aug 8;25(1):996. doi: 10.1186/s12879-025-11414-3.
5
Genome-wide analysis of host-encoded microRNAs modulating SARS-CoV-2 infection.调控新型冠状病毒2019感染的宿主编码微小RNA的全基因组分析。
Sci Data. 2025 Jul 31;12(1):1330. doi: 10.1038/s41597-025-05669-3.
6
SARS-CoV-2 Nsp2 recruits GIGYF2 near viral replication sites and supports viral protein production.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白2(Nsp2)在病毒复制位点附近募集GIGYF2,并支持病毒蛋白的产生。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf674.
7
Integrating AI and CRISPR Cas13a for rapid detection of tomato brown rugose fruit virus.整合人工智能与CRISPR Cas13a用于快速检测番茄褐色皱纹果病毒
Sci Rep. 2025 Jul 14;15(1):25422. doi: 10.1038/s41598-025-11405-z.
8
SUMOylation of SARS-CoV-2 spike protein is a key target for broad-spectrum antiviral therapy.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的类泛素化修饰是广谱抗病毒治疗的关键靶点。
Theranostics. 2025 May 25;15(13):6369-6386. doi: 10.7150/thno.111256. eCollection 2025.
9
Targeting G9a-mA translational mechanism of SARS-CoV-2 pathogenesis for multifaceted therapeutics of COVID-19 and its sequalae.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)发病机制的G9a-甲基化(m⁶A)翻译机制,用于2019冠状病毒病(COVID-19)及其后遗症的多方面治疗。
iScience. 2025 May 11;28(6):112632. doi: 10.1016/j.isci.2025.112632. eCollection 2025 Jun 20.
10
Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection.全基因组siRNA筛选鉴定出对SARS-CoV-2复制及感染后期至关重要的人类宿主因子。
PLoS Biol. 2025 Jun 12;23(6):e3002738. doi: 10.1371/journal.pbio.3002738. eCollection 2025 Jun.
氯喹不能抑制 SARS-CoV-2 感染人肺细胞。
Nature. 2020 Sep;585(7826):588-590. doi: 10.1038/s41586-020-2575-3. Epub 2020 Jul 22.
4
Sars-CoV-2: A clinical update - II.严重急性呼吸综合征冠状病毒2:临床最新进展 - 二
Rev Assoc Med Bras (1992). 2020 Apr;66(4):547-557. doi: 10.1590/1806-9282.66.4.547.
5
Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.鉴定严重急性呼吸综合征冠状病毒 2 的刺突蛋白中的常见缺失。
J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.00790-20.
6
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.严重急性呼吸综合征冠状病毒-2 在 Vero E6 细胞中的复制:复制动力学、快速适应和细胞病变。
J Gen Virol. 2020 Sep;101(9):925-940. doi: 10.1099/jgv.0.001453.
7
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.弗林蛋白酶切割位点在有或无胰蛋白酶存在的情况下,在SARS-CoV-2刺突蛋白介导的膜融合中的作用。
Signal Transduct Target Ther. 2020 Jun 12;5(1):92. doi: 10.1038/s41392-020-0184-0.
8
Big studies dim hopes for hydroxychloroquine.大型研究使人们对羟氯喹的希望破灭。
Science. 2020 Jun 12;368(6496):1166-1167. doi: 10.1126/science.368.6496.1166.
9
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
10
Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.从罕见病中寻找潜在的 COVID-19 疗法:利用脂质失调来对抗病毒感染力。
J Lipid Res. 2020 Jul;61(7):972-982. doi: 10.1194/jlr.R120000851. Epub 2020 May 26.